Literature DB >> 15019165

Analysis of potential prognostic factors in 111 patients with ovarian cancer.

R Hornung1, Eppenberger Urs, Eppenberger Serenella, Wight Edward, Staub Ursula, Haller Urs, Fink Daniel.   

Abstract

The aim of this study was to assess the correlation of survival with clinical, surgical, histopathological, and biochemical parameters in patients with ovarian cancer. Age, surgical and histopathological data, the concentrations of estrogen and progesterone receptors, Her-2 neu, p53, U-PA, PAI-1, and Cathepsin D, DNA-and S-phase indexes of 111 ovarian cancer patients have been analyzed and correlated to survival. Progesterone receptors were correlated with prolonged survival. FIGO staging at the time of diagnosis is an independent prognostic factor for the patient's survival. Endometrioid and serous ovarian cancers have a better prognosis than mucinous and clear cell ovarian cancers. Survival of optimally debulked patients was substantially longer than that of not optimally debulked patients. This study shows, that an accurate clinical and surgical staging with an according histopathological assessment combined with optimal cytoreduction is of importance for the prognosis of ovarian cancer patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019165     DOI: 10.1016/j.canlet.2003.10.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Management of a suspicious adnexal mass: a clinical practice guideline.

Authors:  J E Dodge; A L Covens; C Lacchetti; L M Elit; T Le; M Devries-Aboud; M Fung-Kee-Fung
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

2.  miRNA-612 suppresses ovarian cancer cell tumorigenicity by downregulating NOB1.

Authors:  Zhikun Shi; Xu Zhou; Meijing Bao; Rongxia Jia; Yuqing Chu; Yang Lin
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 3.  Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis.

Authors:  Hui Luo; Saisai Li; Menghuang Zhao; Bo Sheng; Haiyan Zhu; Xueqiong Zhu
Journal:  Oncotarget       Date:  2017-05-30

4.  Prognostic SIGNIFICANCE of Cytoreductive Therapy of Ovarian Cancer - eastern Croatia experience.

Authors:  Zlatko Topolovec; Teodora Horvat; Domagoj Vidosavljević; Siniša Šijanović; Andrijana Müller-Vranješ; Margareta Ugljarević; Dimitrije Milojković; Stjepan Topolovec
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

5.  C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.

Authors:  S Mahner; C Baasch; J Schwarz; S Hein; L Wölber; F Jänicke; K Milde-Langosch
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.